335 results on '"Kim Han W"'
Search Results
2. Myocardial salvage by T2W-CMR: direct comparison to a non-destructive, high resolution, 3-dimensional ex-vivo assessment of the area at risk simultaneous with infarction
3. Rate of acute myocardial infarction in patients with troponin-positive chest pain and unobstructed coronary arteries
4. The ferumoxytol in renal insufficiency study (FiRST)
5. Virtual chemical inversion - a novel fat suppression technique for T1-weighted cardiac imaging with improved delineation of the fat-myocardium interface
6. Detection of acute myocardial infarct with T1-mapping post ferumoxytol contrast administration
7. The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
8. Phase sensitive inversion recovery with simultaneous dark fat rendering by virtual chemical inversion
9. Prognostic value of delayed enhancement cardiovascular magnetic resonance in patients with sarcoidosis
10. A novel index of infarct morphology predicts the presence of microvascular obstruction in patients with acute myocardial infarction
11. Time course of the effect of ferumoxytol on T1-relaxation times of blood, liver, myocardium, and acute infarction
12. Assessment and improvement of image homogeneity in black-blood T2-weighted turbo spin-echo CMR
13. Quantifying the area at risk using the infarct lateral border: importance of infarct transmurality
14. A new CMR protocol for non-destructive, high resolution, ex-vivo assessment of the area at risk simultaneous with infarction: validation with histopathology
15. The relationship of the transmural extent of T2-edema compared with the transmural extent of infarction: implications for the assessment of the area-at-risk
16. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation
17. Adiabatic T2-preparation modules optimized for robustness toward cardiac motion and flow - a comparison with existing techniques at 3 Tesla
18. Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice
19. The Society for Cardiovascular Magnetic Resonance Registry at 150,000
20. Incidence and Predictors of Relapse After Weaning Immune Suppressive Therapy in Cardiac Sarcoidosis
21. Native T1 Mapping for the Diagnosis of Myocardial Fibrosis in Patients With Chronic Myocardial Infarction
22. Myocardial Contractile Mechanics in Ischemic Mitral Regurgitation: Multicenter Data Using Stress Perfusion Cardiovascular Magnetic Resonance
23. Society for Cardiovascular Magnetic Resonance 2021 cases of SCMR and COVID-19 case collection series
24. Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID‐19 infection: The PARACOR‐19 randomized clinical trial
25. ECG-gated MR angiography provides better reproducibility for standard aortic measurements
26. Combined Usage Of CMRI And The Madrid Genotype Score To Identify Genetic Cardiomyopathies
27. Society for Cardiovascular Magnetic Resonance 2020 Case of the Week series
28. MIMICKING THE GREAT MIMICKER: LMNA CARDIOMYOPATHY PRESENTING AS ISOLATED CARDIAC SARCOIDOSIS
29. Assessment of Papillary Muscle Infarction with Dark-Blood Delayed Enhancement Cardiac MRI in Canines and Humans
30. Unexpected Cardiac MRI Findings in Patients Presenting to the Emergency Department for Possible Acute Coronary Syndrome
31. Intracardiac Echinococcal Cyst Causing Biventricular Cavity Obliteration
32. Assessment of myocardial lipomatous metaplasia using an optimized out‐of‐phase cine steady‐state free‐precession sequence: Validation and clinical implementation
33. Suppression of ghost artifacts arising from long T1 species in segmented inversion‐recovery imaging
34. The association with organ procurement techniques and early cardiac transplant outcomes using cardiac MRI.
35. Validation of a novel modified wall motion score for estimation of left ventricular ejection fraction in ischemic and non-ischemic cardiomyopathy
36. PO-638-06 TEMPORAL RELATIONSHIP OF ATRIAL ARRHYTHMIAS WITH THE DIAGNOSIS OF CARDIAC SARCOIDOSIS
37. TIME TO RELAPSE AFTER WEANING IMMUNE SUPPRESSIVE THERAPY IN CARDIAC SARCOIDOSIS: A SINGLE-CENTER EXPERIENCE
38. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
39. Cardiovascular magnetic resonance imaging in suspected cardiac tumour: a multicentre outcomes study
40. Identifying the Etiology: A Systematic Approach Using Delayed-Enhancement Cardiovascular Magnetic Resonance
41. Evaluation of Ischemic Heart Disease
42. Double spectral attenuated inversion recovery (DSPAIR)—an efficient fat suppression technique for late gadolinium enhancement at 3 tesla
43. Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes
44. T1 Mapping in Patients With Nonischemic Cardiomyopathy Undergoing Catheter Ablation
45. Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials – A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study
46. Detection of Left Ventricular Thrombus by Delayed-Enhancement Cardiovascular Magnetic Resonance: Prevalence and Markers in Patients With Systolic Dysfunction
47. Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials – A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study
48. Ablation of Ventricular Tachycardia Storm With Coronary Venous Ethanol
49. Ischemia-Mediated Dysfunction in Subpapillary Myocardium as a Marker of Functional Mitral Regurgitation
50. Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.